Cardiovascular morbidity and mortality in lean vs. non-lean MASLD: A comprehensive meta-analysis

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement

Systematic Reviews · 2015 · 25.2K citations · Full text

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

Jonathan A C Sterne, Miguel A. Hernán, Barnaby C Reeves et al. · BMJ · 2016 · 17.4K citations · Full text

Fixed-Effect vs Random-Effects Models for Meta-Analysis: 3 Points to Consider

Joseph R. Dettori, Daniel C. Norvell, Jens R. Chapman · Global Spine Journal · 2022 · 467 citations · Full text

Meta-analysis, Health Policy, Randomized Controlled Trial +3

Histological severity and clinical outcomes of nonalcoholic fatty liver disease in nonobese patients

Jonathan Chung‐Fai Leung, Thomson Chi‐Wang Loong, Jeremy Lok Wei et al. · Hepatology · 2016 · 338 citations · Full text

Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: A long‐term follow‐up study

Hannes Hagström, Patrik Nasr, Mattias Ekstedt et al. · Hepatology Communications · 2017 · 296 citations · Full text